MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Noninvasive Test Approved for the Evaluation of Coronary Artery Disease

By MedImaging International staff writers
Posted on 14 Jan 2015
Print article
Image: 3-D Representation of the Heart and Coronary Arteries (Photo courtesy of HeartFlow).
Image: 3-D Representation of the Heart and Coronary Arteries (Photo courtesy of HeartFlow).
The US Food and Drug Administration (FDA) have allowed marketing of the HeartFlow (Redwood City, CA, USA) FFR-CT software.

Normally Fractional Flow Reserve (FFR) data is obtained from an invasive cardiac catheterization procedure. The HeartFlow application uses data from a standard Computed Tomography (CT) scan and enables healthcare professionals to measure ischemia, and create a 3-D model of the blood flow in the coronary arteries of a patient with symptoms of coronary heart disease. HeartFlow provides noninvasive evaluation of blockages in coronary arteries using computational fluid dynamics and can help evaluate the effectiveness of placing a stent, angioplasty, or surgery.

In tests HeartFlow FFR-CT was found to be 84%-86% accurate in differentiating significant coronary artery blockages that need revascularization from those that do not, and provides a fast, noninvasive method for the diagnosis of coronary heart disease.

William Maisel, MD, MPH, deputy director for science and chief scientist in the FDA’s Center for Devices and Radiological Health stated, “This noninvasive method is an additional tool for clinicians who are considering the risks and benefits of invasive coronary procedures.”

Related Links:

HeartFlow


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
New
Breast Imaging Workstation
SecurView
New
Ultrasound Table
Ergonomic Advantage (EA) Line

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more